«A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects with Limited-Stage Small-Cell Lung Cancer(LS-SCLC) who Have Not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306) »

ΕΝΕΡΓΟ RECRUITMENT Έναρξη Μελέτης: Φεβ-24 Λήξη Μελέτης: Οκτ-29